Share Facebook Twitter LinkedIn Pinterest Email Eli Lilly said on Saturday its experimental pill orforglipron helped diabetics lose weight and lower their blood sugar, and the company aims to announce in the third quarter trial results for the drug in overweight and obese people without diabetes.
Trump government extends Jones Act waiver by 90 days to dampen oil prices | Donald Trump NewsApril 25, 2026